Key result
Minimal access aortic valve surgery maintains equivalent mortality and reduces hospital stays at similar costs.
Why the study?
With minimally invasive aortic valve approaches and competing transcatheter aortic valve implantation expanding treatment options, there was a need to describe the current state of the art in minimal access aortic surgery.
Minimal access aortic valve surgery is a viable treatment option with equivalent mortality and potential benefits in hospital length of stay.
Answers are grounded in this paper and cite their sources.
Supports minimal access aortic valve surgery for shorter stays; leaves open need for randomized confirmation.
Minimally invasive approaches to the aortic valve have been described since 1993, with great hopes that they would become universal and facilitate day-case cardiac surgery. The literature has shown that these procedures can be undertaken with equivalent mortality, similar operative time, comparative cost and some benefits in hospital length of stay. The competing efforts of the transcatheter aortic valve implantation for these same outcomes have provided an excellent range of treatment options for patients from the Heart Team. We describe the current state of the art, including technical considerations, caveats and complications of minimal access aortic surgery and predict future directions in this space.
No takes yet. Share an insight, caveat, or question.
Kirmani et al. (2023) conducted a review in Aortic valve disease. Minimal access aortic valve surgery was evaluated. Minimal access aortic valve surgery can be undertaken with equivalent mortality, similar operative time, comparative cost, and benefits in hospital length of stay.
Synapse has enriched 10 related papers. Consider them for comparative context: